TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Apr 2025

Income Metrics

Revenue 1.2B
Gross Profit 552.3M 45.58%
Operating Income 451.5M 37.26%
Net Income 405.3M 33.45%
EPS (Diluted) $0.42

Balance Sheet Metrics

Total Assets 9.7B
Total Liabilities 869.5M
Shareholders Equity 8.8B
Debt to Equity 0.10

Cash Flow Metrics

Operating Cash Flow 704.6M
Free Cash Flow 572.9M

Revenue & Profitability Trend

Copart Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i4.2B3.9B3.5B2.7B2.2B
Cost of Goods Sold i2.3B2.1B1.9B1.3B1.2B
Gross Profit i1.9B1.7B1.6B1.3B1.0B
Gross Margin % i45.0%44.9%45.9%49.9%45.7%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i335.2M250.4M231.2M206.7M191.7M
Other Operating Expenses i-----
Total Operating Expenses i335.2M250.4M231.2M206.7M191.7M
Operating Income i1.6B1.5B1.4B1.1B816.1M
Operating Margin % i37.1%38.4%39.3%42.2%37.0%
Non-Operating Items
Interest Income i----1.4M
Interest Expense i--16.7M20.2M18.9M
Other Non-Operating Income-3.1M1.8M-17.4M5.7M3.6M
Pre-tax Income i1.7B1.6B1.3B1.1B800.8M
Income Tax i352.3M316.6M250.8M185.4M100.9M
Effective Tax Rate % i20.5%20.4%18.7%16.5%12.6%
Net Income i1.4B1.2B1.1B936.5M699.9M
Net Margin % i32.2%32.0%31.1%34.8%31.7%
Key Metrics
EBITDA i1.8B1.6B1.5B1.3B924.0M
EPS (Basic) i$1.42$1.30$1.15$0.99$0.75
EPS (Diluted) i$1.40$1.28$1.13$0.98$0.73
Basic Shares Outstanding i960739000953574000949676000945008000932808000
Diluted Shares Outstanding i960739000953574000949676000945008000932808000

Income Statement Trend

Copart Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i1.5B957.4M1.4B1.0B477.7M
Short-term Investments i1.9B1.4B0--
Accounts Receivable i173.7M157.1M137.2M97.2M94.3M
Inventory i43.6M40.0M58.8M45.0M20.1M
Other Current Assets33.9M26.3M18.7M14.3M15.3M
Total Current Assets i4.4B3.3B2.2B1.7B963.8M
Non-Current Assets
Property, Plant & Equipment i116.3M108.1M116.3M119.5M118.5M
Goodwill i1.1B851.3M858.6M757.3M735.0M
Intangible Assets i74.1M62.7M54.7M45.9M47.8M
Long-term Investments-----
Other Non-Current Assets129.4M65.8M47.7M41.8M40.1M
Total Non-Current Assets i4.0B3.5B3.1B2.9B2.5B
Total Assets i8.4B6.7B5.3B4.6B3.5B
Liabilities
Current Liabilities
Accounts Payable i193.3M180.0M187.2M163.2M132.9M
Short-term Debt i21.3M21.5M21.8M22.5M25.6M
Current Portion of Long-term Debt-----
Other Current Liabilities-----
Total Current Liabilities i628.6M492.8M440.9M421.0M356.0M
Non-Current Liabilities
Long-term Debt i97.4M99.0M97.7M495.6M493.0M
Deferred Tax Liabilities i93.7M89.5M80.1M64.0M71.7M
Other Non-Current Liabilities24.5M---430.0K
Total Non-Current Liabilities i250.6M257.7M242.4M611.9M609.7M
Total Liabilities i879.2M750.4M683.3M1.0B965.7M
Equity
Common Stock i96.0K96.0K96.0K24.0K24.0K
Retained Earnings i6.5B5.2B4.0B2.9B1.9B
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i7.5B6.0B4.6B3.5B2.5B
Key Metrics
Total Debt i118.7M120.5M119.5M518.1M518.6M
Working Capital i3.8B2.8B1.8B1.3B607.7M

Balance Sheet Composition

Copart Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i1.4B1.2B1.1B936.5M699.9M
Depreciation & Amortization i190.3M159.7M138.6M123.1M104.3M
Stock-Based Compensation i35.2M39.7M39.0M40.9M23.3M
Working Capital Changes i-89.6M-50.2M-120.4M-111.9M55.9M
Operating Cash Flow i1.5B1.4B1.2B980.7M906.5M
Investing Activities
Capital Expenditures i-506.8M-482.7M-333.1M-460.5M-589.5M
Acquisitions i8.9M-2.7M-109.2M-5.0M-11.7M
Investment Purchases i-4.1B-1.4B-374.9M00
Investment Sales i3.6B0374.9M00
Investing Cash Flow i-940.1M-1.9B-442.3M-465.5M-601.2M
Financing Activities
Share Repurchases i---00
Dividends Paid i-----
Debt Issuance i-----
Debt Repayment i-10.8M-33.9M-417.3M-1.1M-1.1M
Financing Cash Flow i-28.2M-28.1M-420.4M-7.3M-107.3M
Free Cash Flow i961.6M847.6M839.2M527.9M325.9M
Net Change in Cash i529.1M-523.3M301.6M507.9M197.9M

Cash Flow Trend

Copart Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 31.18
Forward P/E 27.06
Price to Book 5.18
Price to Sales 9.92
PEG Ratio 6.24

Profitability Ratios

Profit Margin 32.21%
Operating Margin 37.27%
Return on Equity 18.44%
Return on Assets 12.02%

Financial Health

Current Ratio 8.16
Debt to Equity 1.15
Beta 1.04

Per Share Data

EPS (TTM) $1.51
Book Value per Share $9.08
Revenue per Share $4.76

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
cprt45.5B31.185.1818.44%32.21%1.15
Cintas 86.4B48.8118.4340.27%17.53%56.67
Global Payments 21.0B14.760.936.59%14.20%71.17
Rb Global 19.9B52.983.777.39%9.68%76.45
Ul Solutions 13.4B41.2512.2836.55%11.08%72.33
Rentokil Initial plc 12.5B38.3311.565.13%4.46%115.51

Financial data is updated regularly. All figures are in the company's reporting currency.